SCHEMBL6205181

SCHEMBL6205181

O=C(O)ON1CCC(c2ccc(Cl)cc2)CC1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 4/20 0.48
SLC18A3 Q16572 1/20 0.48
DRD2 P14416 2/20 0.47
IDO1 P14902 1/20 0.47
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
GRM5 P41594 1/20 0.45
CCR1 P32246 8/20 0.44
KCNH2 Q12809 1/20 0.44
NPC1 O15118 1/20 0.44
LMNA P02545 1/20 0.44
TP53 P04637 1/20 0.44
MAPT P10636 1/20 0.44
NFKB1 P19838 1/20 0.44
RAB9A P51151 1/20 0.44
NFKB2 Q00653 1/20 0.44
RELA Q04206 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
USP5 P45974 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27594938 0.83 DRD2 (0.48) HSD11B1SLC18A3DRD2IDO1GRM5
SCHEMBL3546582 0.79 NPC1 (0.46) HSD11B1SLC18A3DRD2GRM5NPC1
SCHEMBL2098866 0.78 HSD11B1 (0.58) HSD11B1SLC18A3DRD2IDO1GRM5
Bicarbonate SCHEMBL1719769 0.77 IDO1 (0.51) HSD11B1SLC18A3DRD2IDO1MEN1
SCHEMBL29055984 0.76 FPR2 (0.45)
SCHEMBL16963363 0.75 CCR1 (0.57) HSD11B1SLC18A3DRD2IDO1GRM5
SCHEMBL19658652 0.73 QDPR (0.62) HSD11B1DRD2IDO1CCR1KCNH2
Carbamic Acid SCHEMBL1569088 0.73 IDO1 (0.49) HSD11B1SLC18A3DRD2IDO1MEN1
Bicarbonate SCHEMBL11118762 0.73 BCL2L1 (0.50) HSD11B1SLC18A3DRD2IDO1SMN1; SMN2
Acetic Acid SCHEMBL28980245 0.73 IDO1 (0.49) HSD11B1SLC18A3DRD2IDO1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1597228-A2 SUBSTITUTED N-ARYLHETEROCYCLES, METHOD FOR PRODUCTION AND USE THEREOF AS MEDICAMENTS Sanofi-Aventis Deutschland GmbH (DE) 2005-11-23 EP disclosed
WO-2004072025-A2 SUBSTITUTED N-ARYLHETEROCYCLES, METHOD FOR PRODUCTION AND USE THEREOF AS MEDICAMENTS AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2004-08-26 WO disclosed